By what mechanism does the rosiglitazone cause an increased risk of MI but pioglitazone does not have this effect?
Studies have suggested that Rosiglitazone may increase the risk of heart attack by as much as 43% . In some countries it has been taken off the market and in others it is only available under significant restrictions. Patients should be advised of alternative options.
Pioglitazone has a cardiovascular safety profile that compares favorably with rosiglitazone. However, pioglitazone has subsequently been found to be associated with bladder tumors and has been withdrawn in some countries.
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 19 Dec 2009 • 1 answer
Posted 3 Jul 2012 • 1 answer
Posted 10 Aug 2014 • 1 answer
Posted 6 Jan 2016 • 0 answers
Posted 23 Jan 2018 • 0 answers